Article Versions Notes

Iannuzzo G, Gentile M, Bresciani A, Mallardo V, Di Lorenzo A, Merone P, Cuomo G, Pacileo M, Sarullo FM, Venturini E, et al. Inhibitors of Protein Convertase Subtilisin/Kexin 9 (PCSK9) and Acute Coronary Syndrome (ACS): The State-of-the-Art. Journal of Clinical Medicine. 2021; 10(7):1510. https://doi.org/10.3390/jcm10071510

Iannuzzo, Gabriella, Marco Gentile, Alessandro Bresciani, Vania Mallardo, Anna Di Lorenzo, Pasquale Merone, Gianluigi Cuomo, Mario Pacileo, Filippo M. Sarullo, Elio Venturini, and et al. 2021. "Inhibitors of Protein Convertase Subtilisin/Kexin 9 (PCSK9) and Acute Coronary Syndrome (ACS): The State-of-the-Art" Journal of Clinical Medicine 10, no. 7: 1510. https://doi.org/10.3390/jcm10071510

Iannuzzo, G., Gentile, M., Bresciani, A., Mallardo, V., Di Lorenzo, A., Merone, P., Cuomo, G., Pacileo, M., Sarullo, F. M., Venturini, E., D’Andrea, A., Vigorito, C., & Giallauria, F. (2021). Inhibitors of Protein Convertase Subtilisin/Kexin 9 (PCSK9) and Acute Coronary Syndrome (ACS): The State-of-the-Art. Journal of Clinical Medicine, 10(7), 1510. https://doi.org/10.3390/jcm10071510